4-氨基-5-氰基-6-烷胺基吡啶衍生物的合成与生物活性

采用六水合硝酸锌作催化剂、少量的乙醇钠为助催化剂,使用无水乙醇作为溶剂,将2-氰基-3-烷胺基-3-氨基-丙烯腈(N,N-缩醛)与β-二羰基化合物一步关环生成了一系列目标化合物4-氨基-5-氰基-6-烷胺基吡啶衍生物.通过1H NMR,IR,EI-MS,元素分析等方法对所合成的化合物进行了结构表征.代表化合物2-甲基-4-氨基-5-氰基-6-乙醇胺基-3-乙氧羰基吡啶经单晶X衍射证实了结构.对合成的多取代吡啶衍生物化合物作了初步的农药活性测试,测试结果表明:所合成的多取代吡啶衍生物部分化合物表现出较好的杀菌活性,同时也对油菜和稗草具有一定的除草活性.     

含吡啶环的N-(1,3,4-噻二唑-2-基)苯甲酰胺类化合物的合成及其抑菌活性

以3-吡啶乙酸盐酸盐与氨基硫脲为原料经环化反应制备中间体2-氨基-5-(3-吡啶亚甲基)-1,3,4-噻二唑,后者与取代苯甲酰氯反应合成了一系列含吡啶环的N-(1,3,4-噻二唑-2-基)取代苯甲酰胺(3a~3k),其结构通过IR、~1H NMR、~(13)C NMR、MS和元素分析确证。用菌丝生长速率法测定了目标化合物对灰霉菌的离体抑菌活性,结果表明,部分化合物对病原菌有一定的抑制活性。     

噻吩甲酰胺衍生物的合成及其对小麦全蚀病病原菌的抑制活性

探索了取代2-氢噻吩-3-羰基酸酯的合成及其硅烷化的方法,并对反应条件进行了优化;以其为母体合成了20个未见有报道的噻吩甲酰胺衍生物;各噻吩甲酰胺衍生物的结构经1H NMR,13C NMR,HRMS或元素分析确证;其对小麦全蚀病病原菌的抑菌活性经平皿法进行了测试.初步结构活性分析表明,噻吩甲酰胺胺基取代基结构的变化及其2位官能团的大小对小麦全蚀病病原菌抑制活性有显著的影响,其中化合物7b~7d,7l,7m,7o表现出了优异的抑菌活性.该结果对抑菌先导化合物的设计具有一定的参考价值.     

N-[4-氯-2-取代氨基甲酰基-6-甲基苯基]-1-芳基-5-氯-3-三氟甲基-1H-吡唑-4-甲酰胺的合成及生物活性

通过改变传统氯虫酰胺中吡唑环上氨基甲酰基与吡啶环之间的相对位置, 或以其它芳环取代原分子中的吡啶环, 设计合成了24个结构新颖的N-[4-氯-2-取代氨基甲酰基-6-甲基苯基]-1-芳基-5-氯-3-三氟甲基-1H-吡唑-4-甲酰胺类化合物. 所有目标化合物的结构均通过¹H NMR谱、 元素分析或高分辨质谱表征确定. 初步的生物活性测试结果表明, 部分化合物对东方粘虫具有较好的杀虫活性, 其中化合物6m在浓度为50 mg/L时具有80%的杀虫活性. 同时, 在浓度为50 mg/L时目标化合物对5种常见病菌具有明显的抑制作用, 其中化合物6n和6x对苹果轮纹菌的抑菌率达62.1%.     

取代3—氨基嘧啶及其噻吩磺酰脲衍生物的合成和除草活性

采用克莱森缩合反应合成了６个β－二羰基化合物（Ⅰ），Ⅰ与胍的缩合环化反应等合成了７个取代２－氨基嘧啶（Ⅱ）、Ⅱ与２－噻吩磺酰异氰酸酯反应合成了５个含不同取代嘧啶环的２－噻吩磺酰脲（Ⅲ）、Ⅱ和Ⅲ中有８个首次合成，其结构经ＩＲ，＾１ＨＮＭＲ，元素分析等测试确证，并初步测定了部分化合物的除草活性。     

2-氨基(芳氧基)-3-对甲基苯基噻吩并[3',2':5,6]吡啶并[4,3-d]嘧啶-4(3H)-酮的合成和生物活性

用邻氨基噻吩腈与乙酰乙酸甲酯为原料,利用串联Aza-Wittig法合成了9个未见文献报道的噻吩并吡啶并嘧啶类化合物,通过IR,1H NMR,EI-MS,元素分析等方法对所合成的化合物进行了结构表征,并初步测定了所合成化合物的杀菌活性.生测结果表明:此类化合物对棉花枯萎(Fusarium oxysporium)、水稻纹枯(Rhizoctonia solani)、小麦赤霉(Gibberella zeae)、苹果轮纹菌(Dothiorella gregaria)、棉花炭疽菌(Colletotrichum gossypii)等5种菌均有一定的抑制活性.其中对苹果轮纹菌抑制活性最好,在浓度为5.0×10-5g/mL时抑制率为31.80%～82.84%.     

四氢苯并[4',5']噻吩并[3',2':5,6]吡啶并[4,3-d]嘧啶-4(3H)-酮的合成、晶体结构及杀菌活性

通过氮杂Wittig反应合成了一系列结构新颖的未见文献报道的取代四氢苯并[4',5']噻吩并[3',2':5,6]吡啶并[4,3-d]嘧啶-4(3H)-酮化合物6, 产物的结构通过核磁共振氢谱、质谱、红外光谱、元素分析的确证. 为进一步了解此类化合物的结构, 对化合物6c进行了X射线单晶衍射. 初步杀菌活性测定结果表明, 该类化合物具有较好的杀菌活性和选择性. 如6f在50 mg/L浓度时, 对黄瓜灰霉菌的抑制率为98%.     

新型四氢苯并[4',5']噻吩并[3',2'∶5,6]吡啶并[4,3-d]嘧啶类化合物衍生物的合成及抗肿瘤活性

本文以环己酮为原料,通过氮杂Wittig反应合成了一系列结构新颖的取代四氢苯并噻吩并吡啶并嘧啶衍生物,并采用MTT法考察所合成目标化合物对CNE2、KB、MGC-803、MCF-7和PC3这5种肿瘤细胞的抑制活性。初步的生物活性结果表明,目标化合物对5种肿瘤细胞均有抑制活性,尤其是对胃癌MGC-803细胞展现出了更强的抑制活性。其中3-(4-氟苯基)-2-((4-氟苯基)氨基)-5-甲基-8,9,10,11-四氢苯并[4',5']噻吩并[3',2':5,6]吡啶并[4,3-d]嘧啶-4(3H)-酮[化合物8c,IC_(50)=(0. 9±0. 25)μmol·L~(-1)]对MGC-803的活性最强,是5-氟尿嘧啶[IC_(50)=(18. 4±1. 43)μmol·L~(-1)]的20倍;同时,目标化合物对正常的胃黏膜上皮细胞GES-1没有毒性。四氢苯并[4',5']噻吩并[3',2':5,6]吡啶并[4,3-d]嘧啶类化合物具有良好的抗肿瘤活性,值得进一步深入研究。     

2-位或4-位取代吡啶并嘧啶类非经典叶酸拮抗剂的合成及抗肿瘤活性

以非经典叶酸拮抗剂2,4-二氨基-6-(4-甲基苯基)乙基吡啶并[3,2-d]嘧啶(wm-5b)及其侧链简化产物2,4-二氨基吡啶并[3,2-d]嘧啶为先导化合物, 选取具有抗肿瘤活性的基团, 通过微波法高效合成了2-位或4-位取代吡啶并嘧啶类非经典叶酸拮抗剂, 研究了2-位及4-位取代基对抗肿瘤活性的影响, 为非经典叶酸拮抗剂的设计合成提供了更多的理论依据. 目标化合物的结构均经核磁共振波谱(NMR)和质谱(MS)确证. 生物活性测定结果表明, 所有目标化合物均具有抗肿瘤活性, 其中, 6-(4-甲基苯基)乙基-4-氨基-2-(3-氯-4-氟苯基)氨基吡啶并[3,2-d]嘧啶(6b)对HL-60细胞的IC₅₀=(4.09±0.48) μmol/L, 对A549细胞的IC₅₀=(17.99±7.20) μmol/L, 而对HCT116细胞的IC₅₀=(14.52±4.74) μmol/L; 部分目标化合物具有二氢叶酸还原酶抑制活性. 此外, 对部分目标化合物和先导物进行了二氢叶酸还原酶晶体结构的分子对接, 对活性结果和构效关系从分子水平上进行解释.     

新型噻吩并四氢吡啶类化合物的合成及其抗血小板聚集活性

噻吩并［3,2-c］四氢吡啶和噻吩并［2,3-c］四氢吡啶分别与取代苄溴(2a~2g)经取代反应后,用2 mol·L^-1氯化氢乙醚溶液成盐合成了噻吩并四氢吡啶衍生物(3b~3e, 3g和5a~5g);噻吩并［3,2-c］四氢吡啶酮与取代苄溴经取代反应,再与乙酸酐缩合,最后经2 mol·L^-1氯化氢乙醚溶液成盐合成了噻吩并四氢吡啶衍生物(7d, 7e, 7g~7i)。 3, 5和7均为新化合物,其结构经¹H NMR 和ESI-MS表征。大鼠体内抗血小板聚集活性研究结果表明：3, 5和7均有一定的抗血小板聚集活性,其中7d, 7h和7i的抑制率分别为66.2%, 86.8%和88.3%,活性优于阳性对照药噻氯匹啶。     

Synthesis, reactions and biological activity of 2-substituted 3-cyano-4,6-dimethylpyridine derivatives

The reaction of 2-chloro-4,6-dimethylpyridine-3-carbonitrile with hydrazine hydrate, hydroxylamine, and anthranilic acid afforded the corresponding pyrazolo, isoxazolo, and pyridoquinazoline derivatives. Alkylation of 2-mercapto-4,6-dimethylpyridine-3-carbonitrile with ethyl chloroacetate or phenacyl bromide followed by cyclization in NaOH gave thienopyridine derivatives. Diazotization of ethyl 3-amino-4,6-dimethylthiеno[2,3-b]pyridine-2-carboxylate followed by the reaction with thiourea, guanidine carbonate, and hydroxylamine hydrochloride gave the corresponding thienopyridine derivatives. The biological activity of some new compounds has been discussed. Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 1, pp. 43–51, Januar, 2009.     

Utilization of 2‐Chloronicotinonitrile in the Syntheses of Novel Fused Bicyclic and Polynuclear Heterocycles of Anticipated Antitumor Activity

Some of synthetic bicyclic and polynuclear heterocyclic compounds based on pyridine scaffold were tested as in vitro antitumor agents, and these compounds found to exhibit interesting activities. Fused heterocycles containing sulfur such as thienopyridine, pyridothiazine, and some related fused heterocycles as new ring systems were achieved. Bicyclic thienopyridine 6 and pyrido[3,2‐e][1,3]thiazin‐4(3H)‐one 7 exhibited good antitumor activities compared with 5‐fluorouracil.     

Synthesis and antibacterial activities of pleuromutilin derivatives

Six new pleuromutilin derivatives were designed and synthesized, confirmed by MS, IR and 1H NMR techniques. And the antibacterial activities were primarily evaluated in vitro. The results indicated that most of the derivatives showed more potent activities against corresponding bacterial strains than that of pleuromutilin. Especially, compounds 4d and 5b had obvious activities against salmonella compared with pleuromutifin.     

Synthesis of New Thienopyridine Derivatives by a Reaction of 4‐(Methylsulfanyl)‐6,7‐dihydrothieno[3,2‐c]pyridine with Amino Acids

New thienopyridine derivatives were synthesized by the reaction of 4‐(methylsulfanyl)‐6,7‐dihydrothieno[3,2‐c]pyridine ( 5 ) with amino acids. The use of β‐amino acids led to thienopyridopyrimidone derivatives ( 9a–g ). Using α‐amino acids, such as glycine and racemic alanine under the same reaction conditions, compounds with two thienopyridine units were obtained. The structure of the novel compounds was confirmed by IR, ¹³C, and ¹H NMR spectroscopy, as well as mass spectrometry, along with single crystal X‐ray analysis. © 2013 Wiley Periodicals, Inc. Heteroatom Chem 24:124–130, 2013; View this article online at wileyonlinelibrary.com . DOI 10.1002/hc.21073     

ENAMINONES AS BUILDING BLOCKS IN ORGANIC SYNTHESIS: SYNTHESIS OF NEW POLYFUNCTIONAL PYRIDINES,CONDENSED PYRIDINES,AND PENTA SUBSTITUTED BENZENE

ABSTRACT

Several new thienopyridine and methylthioether derivatives have been synthesized. New synthesis of pyrido[2,3-b]-thieno[3,2-d]pyrimidine and penta substituted benzene were achieved.     

A New Version of Multicomponent Synthesis of 4,6-Diaryl-2-sulfanylidene-1,2-dihydropyridine-3-carbonitrile Derivatives

Multicomponent condensation of aromatic aldehydes with acetophenones, cyanothioacetamide, and alkylating agents has been shown to provide synthetic routes to various pyridine and thienopyridine derivatives. The structure of some of the synthesized heterocycles has been confirmed by X-ray analysis.     

Synthesis of some new 2-substituted-4-sulfamoylphenylazo-thiophene and/or thiazole derivatives as antibacterial agents

Benzoylacetone has been reacted with phenyl isothiocyanate to afford two different thiocarbamoyl derivatives (α-phenylthiocarbamoyl benzoylacetone and benzoyl thioacetanilide) depending upon the base used to perform the reaction. Several new 2-substituted-4-sulfamoylphenylazo-thiophene and/or thiazole derivatives were synthesized by heterocyclization of the thiocarbamoyl derivatives with various halogenated reagents. The synthesized compounds were screened for their antibacterial activities; they showed accepted activities with respect to the control drugs.     

含杂环1,4-戊二烯-3-酮肟酯类化合物的合成及生物活性

为创制具有较高生物活性的绿色农药,以姜黄素为先导,将具有良好生物活性的肟酯基团引入1,4-戊二烯-3-酮的骨架中,设计合成了一系列含杂环1,4-戊二烯-3-酮肟酯类化合物,其结构经红外光谱、核磁共振氢谱及碳谱和高分辨质谱确认。初步的生物活性测试结果表明,在药剂浓度为50mg/L时,化合物5d对小麦赤霉病菌,水稻纹枯病菌和苹果腐烂病菌的抑制活性相对较好,分别为64.75%、52.05%和69.68%;在药剂浓度为500mg/L时,化合物5d、5e和5f对TMV具有较好的治疗和钝化活性,其抑制率分别为56.93%和86.89%、53.08%和83.51%、53.40%和89.01%。以上研究结果表明,1,4-戊二烯-3-酮肟酯类化合物具有一定抑菌和抗病毒活性,在其结构基础上进行适当的改造,有望获得具有较高生物活性的有机分子。